Last quarter (Q4 2023), Agios Pharma's total revenue was $7.10M, an increase of Infinity% from the same quarter last year. In Q4, Agios Pharma's net income was $-95.94M. See Agios Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 26.82M	$ 26.82M	$ 14.24M	$ 500.00K	$ 0.00	$ 117.91M
Cost of Revenue	$ 2.88M	$ 2.88M	$ -1.70M	-	$ 2.81M	$ 1.32M
Gross Profit	$ 23.94M	$ 23.94M	$ 12.54M	$ 500.00K	$ 200.39M	$ 116.59M
Operating Expense	$ 415.43M	$ 415.43M	$ 401.58M	$ 378.42M	$ 335.92M	$ 542.93M
Operating Income	$ -391.49M	$ -391.49M	$ -389.05M	$ -378.42M	$ -335.92M	$ -426.33M
Net Non Operating Interest Income Expense	$ 49.69M	$ 33.34M	$ 140.65M	$ 836.00K	$ 6.61M	$ 14.86M
Other Income Expense	$ 10.29M	$ -6.05M	$ -6.75M	$ -14.43M	-	-
Pretax Income	$ -352.09M	$ -352.09M	$ -231.80M	$ -356.51M	$ -329.31M	$ -411.47M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -352.09M	$ -352.09M	$ -231.80M	$ -356.51M	$ -327.37M	$ -411.47M
Basic EPS	$ -6.34	$ -12.66	$ -4.23	$ 26.55	$ -4.74	$ -6.86
Diluted EPS	$ -6.34	$ -12.66	$ -4.23	$ 26.55	$ -4.74	$ -6.86
Basic Average Shares	$ 222.61M	$ 55.65M	$ 54.79M	$ 60.45M	$ 69.00M	$ 59.99M
Diluted Average Shares	$ 222.61M	$ 55.65M	$ 54.79M	$ 60.45M	$ 69.00M	$ 59.99M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 418.31M	$ 418.31M	$ 399.88M	$ 378.42M	$ 335.92M	$ 544.25M
Net Income From Continuing And Discontinued Operation	$ -352.09M	$ -352.09M	$ -231.80M	$ -356.51M	$ -327.37M	$ -411.47M
Normalized Income	$ -214.15M	$ -278.15M	-	-	$ -329.31M	$ -411.47M
Interest Expense	-	-	-	-	$ 17.83M	$ 0.00
EBIT	$ -352.09M	$ -352.09M	$ -231.80M	$ -356.51M	$ -335.92M	$ -411.47M
EBITDA	$ -339.80M	$ -339.80M	$ -214.44M	$ -330.78M	$ -326.13M	$ -403.38M

Currency in USD

Agios Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing